Objectives: Infertility affects approximately 80 million people worldwide. The prevalence ranges from 8-10% among developed countries. Infertility poses an increased challenge however, there are several medical interventions could be identified that could contribute to the successful conception. The aim of our study was to determine the epidemiological disease burden of female infertility of other origin in Hungary.

Methods: Data were derived from the financial database of the Hungarian National Health Insurance Fund Administration (NHIFA), of the year 2019. Data analysed included annual number of patients, number of cases, and prevalence of the utilization per 100,000 population according to age groups. The following health insurance treatment categories were included into our study: general practice care, home care, in- and outpatient care, medical imaging, laboratory diagnostics, pharmaceuticals and medical aids. Patients with female infertility of other origin were identified with the following code of the International Classification of Diseases 10^th revision: N9780.

Results: The highest number of patients were found in outpatient care (3,780 women), followed by pharmaceuticals (1,759 women) and laboratory diagnostics (1,618 women). The mean age of the patients was 36.2 years in outpatient care. Based on number of patients related to the outpatient care, the prevalence among women was 74.0 patients in in 100,000 inhabitants. Age specific prevalence was the highest within the age group of 30-39 years (333.81women) and 40-49 years (135.84 women).

Conclusions: The results showed that the highest number of patients was in the outpatient care. The prevalence of female infertility of other origin showed significant differences by age groups. The most affected age group was women in 30-39 ages, which was 1.99 times higher than number of patients of 40-49 years age group. Thus the early diagnosis, proper medical intervention and medication affect the successful childbearing and the quality of life of women.